Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia

Por Mosakhani, Neda, Mustjoki, Satu, Knuutila, Sakari
Publicado em 2013

STAT5b in LGL leukemia – a novel therapeutic target?

Por Rajala, Hanna L. M., Mustjoki, Satu
Publicado em 2013

IFNα induces prolonged remissions modeling curative immunologic responses in chronic myeloid leukemia

Por Ilander, Mette, Kreutzman, Anna, Mustjoki, Satu
Publicado em 2014

Dasatinib promotes Th1-type responses in granzyme B expressing T-cells

Por Kreutzman, Anna, Ilander, Mette, Porkka, Kimmo, Vakkila, Jukka, Mustjoki, Satu
Publicado em 2014

A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34)

Por Mustjoki, Satu, Hernesniemi, Sari, Rauhala, Auvo, Kähkönen, Marketta, Almqvist, Anders, Lundán, Tuija, Porkka, Kimmo
Publicado em 2009

Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-α Monotherapy

Por Ilander, Mette, Kreutzman, Anna, Rohon, Peter, Melo, Teresa, Faber, Edgar, Porkka, Kimmo, Vakkila, Jukka, Mustjoki, Satu
Publicado em 2014

Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia

Por Christiansson, Lisa, Söderlund, Stina, Svensson, Emma, Mustjoki, Satu, Bengtsson, Mats, Simonsson, Bengt, Olsson-Strömberg, Ulla, Loskog, Angelica S. I.
Publicado em 2013

A novel class of somatic mutations in blood detected preferentially in CD8 + cells

Por Valori, Miko, Jansson, Lilja, Kiviharju, Anna, Ellonen, Pekka, Rajala, Hanna, Awad, Shady Adnan, Mustjoki, Satu, Tienari, Pentti J.
Publicado no Clin Immunol (2017)

Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia

Por El Missiry, Mohamed, Hjorth-Hansen, Henrik, Richter, Johan, Olson-Strömberg, Ulla, Stenke, Leif, Porkka, Kimmo, Kreutzman, Anna, Mustjoki, Satu
Publicado no PLoS One (2017)

Genomic landscape characterization of large granular lymphocyte leukemia with a systems genetics approach

Por Coppe, A, Andersson, E I, Binatti, A, Gasparini, V R, Bortoluzzi, S, Clemente, M, Herling, M, Maciejewski, J, Mustjoki, S, Bortoluzzi, S
Publicado no Leukemia (2017)

Immune cell phenotype and functional defects in Netherton syndrome

Por Elina Eränkö, Mette Ilander, Mirja Tuomiranta, Antti Mäkitie, Tea Lassila, Anna Kreutzman, Paula Klemetti, Satu Mustjoki, Katariina Hannula-Jouppi, Annamari Ranki
Publicado em 2018-11-01

The SCLtTAxBCR-ABL transgenic mouse model closely reflects the differential effects of dasatinib on normal and malignant hematopoiesis in chronic phase-CML patients

Por Schubert, Claudia, Chatain, Nicolas, Braunschweig, Till, Schemionek, Mirle, Feldberg, Kristina, Hoffmann, Melanie, Dufva, Olli, Mustjoki, Satu, Brümmendorf, Tim H., Koschmieder, Steffen
Publicado no Oncotarget (2017)

A Molecular and Functional Analysis of Large Granular Lymphocyte Expansions in Chronic Myelogenous Leukemia Patients Treated With Tyrosine Kinase Inhibitors

Por Powers, John J., Dubovsky, Jason A., Epling-Burnette, PK, Moscinski, Lynn, Zhang, Ling, Mustjoki, Satu, Sotomayor, Eduardo M., Pinilla-Ibarz, Javier A.
Publicado no Leuk Lymphoma (2011)

Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity

Por Schiffer, Charles A., Cortes, Jorge E., Hochhaus, Andreas, Saglio, Giuseppe, le Coutre, Philipp, Porkka, Kimmo, Mustjoki, Satu, Mohamed, Hesham, Shah, Neil P.
Publicado no Cancer (2016)

<i>STAT3</i> Mutation Is Associated with STAT3 Activation in CD30⁺ ALK⁻ ALCL

Por Emma I. Andersson, Oscar Brück, Till Braun, Susanna Mannisto, Leena Saikko, Sonja Lagström, Pekka Ellonen, Sirpa Leppä, Marco Herling, Panu E. Kovanen, Satu Mustjoki
Publicado em 2020-03-01

Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-α Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile

Por Kreutzman, Anna, Rohon, Peter, Faber, Edgar, Indrak, Karel, Juvonen, Vesa, Kairisto, Veli, Voglová, Jaroslava, Sinisalo, Marjatta, Flochová, Emília, Vakkila, Jukka, Arstila, Petteri, Porkka, Kimmo, Mustjoki, Satu
Publicado em 2011

Deep sequencing of the T-cell receptor repertoire in CD8(+) T-large granular lymphocyte leukemia identifies signature landscapes

Por Clemente, Michael J., Przychodzen, Bartlomiej, Jerez, Andres, Dienes, Brittney E., Afable, Manuel G., Husseinzadeh, Holleh, Rajala, Hanna L. M., Wlodarski, Marcin W., Mustjoki, Satu, Maciejewski, Jaroslaw P.
Publicado em 2013

Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation

Por Shady Adnan Awad, Oscar Brück, Naranie Shanmuganathan, Timo Jarvinen, Hanna Lähteenmäki, Jay Klievink, Hazem Ibrahim, Soili Kytölä, Perttu Koskenvesa, Timothy P. Hughes, Susan Branford, Matti Kankainen, Satu Mustjoki
Publicado em 2022-04-01

Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation

Por Andersson, E I, Rajala, H L M, Eldfors, S, Ellonen, P, Olson, T, Jerez, A, Clemente, M J, Kallioniemi, O, Porkka, K, Heckman, C, Loughran, T P, Maciejewski, J P, Mustjoki, S
Publicado em 2013

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

Por Mäkinen, Taija, Veikkola, Tanja, Mustjoki, Satu, Karpanen, Terhi, Catimel, Bruno, Nice, Edouard C., Wise, Lyn, Mercer, Andrew, Kowalski, Heinrich, Kerjaschki, Dontscho, Stacker, Steven A., Achen, Marc G., Alitalo, Kari
Publicado em 2001